Skip to content
Disclosery

Boston Trust Walden Corp: AXP position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Boston Trust Walden Corp on AXP, newest first. How the timeline and the estimate are built.

Boston Trust Walden Corp held 2,536,826 AXP shares at 2026-06-30 per its 13F-HR filed 2026-08-04.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 2,536,826 shares
    Change vs previous 13F +254,079 shares

    0.68% of the 13F portfolio, value $860,504,531.

    13F-HR 0001386060-26-000035 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 2,312,355 shares
    • Boston Trust Walden Corp: 224,471 shares

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 2,282,747 shares
    Change vs previous 13F -40,707 shares

    0.64% of the 13F portfolio, value $690,217,101.

    13F-HR 0001386060-26-000017 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 2,056,161 shares
    • Boston Trust Walden Corp: 226,586 shares

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 2,323,454 shares
    Change vs previous 13F -99,228 shares

    0.78% of the 13F portfolio, value $858,195,576.

    13F-HR 0001386060-26-000014 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 2,083,328 shares
    • Boston Trust Walden Corp: 240,126 shares

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 2,422,682 shares
    Change vs previous 13F +36,949 shares

    0.72% of the 13F portfolio, value $803,791,367.

    13F-HR 0001386060-25-000020 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 2,179,896 shares
    • Boston Trust Walden Corp: 242,786 shares

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F/A 2,385,733 shares
    Change vs previous 13F +202,978 shares

    0.73% of the 13F portfolio, value $758,572,546.

    13F-HR/A 0001085146-25-004915 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 2,088,642 shares
    • Boston Trust Walden Corp: 297,091 shares

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 2,182,755 shares
    Change vs previous 13F +40,175 shares

    0.61% of the 13F portfolio, value $585,605,673.

    13F-HR 0001085146-25-002987 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 1,957,784 shares
    • Boston Trust Walden Corp: 224,971 shares

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 2,142,580 shares
    Change vs previous 13F -187,830 shares

    0.66% of the 13F portfolio, value $638,477,629.

    13F-HR 0001085146-25-000961 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 1,923,899 shares
    • Boston Trust Walden Corp: 218,681 shares

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 2,330,410 shares
    Change vs previous 13F not available

    0.64% of the 13F portfolio, value $631,961,126.

    13F-HR 0001085146-24-005518 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 2,109,771 shares
    • Boston Trust Walden Corp: 220,639 shares

    Acceptance time not in the bulk data set (spec §4.2).